source
- Former Orbital scientists launch ParcelBio with $13 million seed round to boost mRNA therapy durabilityTwo former Orbital Therapeutics scientists, Chris Carlson and David Weinberg, have founded a new company called ParcelBio. The startup aims to address a technical limitation that has hindered the…
- PhRMA launches seven-figure ad campaign against 340B drug discount programPhRMA, the leading pharmaceutical lobbying group, announced a new advertising push aimed at the federal 340B drug discount program. The campaign, described as a seven-figure effort, is set to begi…